Elevated expression of bisecting N-acetylglucosaminyltransferase-III gene in a human fetal hepatocyte cell line by hepatitis B virus

Journal of Gastroenterology and Hepatology (Australia)

Volumn 19, Issue 12, 2004, Pages 1374-1387

  Shim, Jae Kyoung ^a   Lee, Young Choon ^b   Chung, Tae Ho ^c   Kim, Cheor Ho ^a  

^a Dongguk University   (South Korea)

^b Dong A University   (South Korea)

^c Kyungpook National University   (South Korea)

Author keywords

Hepatitis B virus; Hepatocellular carcinoma; HFH T2; N acetylglucosaminyltransferase III (GnT III); fetoprotein

Indexed keywords

ALPHA FETOPROTEIN; GLYCOSYLTRANSFERASE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY GT273; N ACETYLGLUCOSAMINYLTRANSFERASE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE N ACETYLGLUCOSAMINE;

ARTICLE; DENSITY GRADIENT CENTRIFUGATION; DNA DETERMINATION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; LIVER CELL CULTURE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS GENOME; VIRUS PARTICLE; VIRUS TRANSFORMATION; WESTERN BLOTTING;

EID: 11144221635     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0815-9319.2004.03473.x     Document Type: Article

References (54)

1. Feizi T. Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are onco-developmental antigens. Nature 1985; 314: 353-7.
2. Hakomori S. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv. Cancer Res. 1989; 52: 257-331.
3. Ishibashi K, Nishikawa A, Hayashi N et al. N- acetylglucosaminyltransferase III in human serum, and liver and hepatoma tissues: increased activity in liver cirrhosis and hepatoma patients. Clin. Chim. Acta 1989; 185: 325-32.
4. Mizoguchi A, Takasaki S, Maeda S, Kobata A. Changes in asparagine-linked sugar chains of human promyelocytic leukemic cells (HL-60) during monocytoid differentiation and myeloid differentiation. Decrease of high-molecular-weight oligosaccharides in acidic fraction. J. Biol. Chem. 1984; 259: 11949-57.
5. Dennis JW, Laferte S, Waghorne C, Breitman ML, Kerbel RS. β1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science 1987; 236: 582-5.
6. Narasimhan S. Control of glycoprotein synthesis. UDP-GlcNAc: glycopeptide beta 4-N-cetylglucosaminyltransferase III, an enzyme in hen oviduct which adds GlcNAc in β1-4 linkage to the β-linked mannose of the trimannosyl core of N-glycosyl oligosaccharides. J. Biol. Chem. 1982; 257: 10235-42.
7. Nishikawa N, Fujii S, Sugiyama T, Taniguchi N. A method for the determination of N-acetylglucosaminyltransferase III activity in rat tissues involving HPLC. Anal. Biochem. 1988; 170: 349-54.
8. Nishikawa A, Fujii S, Sugiyama T, Hayashi N, Taniguchi N. High expression of an N-acetylglucosaminyltransferase III in 3′-methyl DAB-induced hepatoma and ascites hepatoma. Biochem. Biophys. Res. Commun. 1988; 152: 107-12.
9. Nishikawa A, Gu J, Fujii S, Taniguchi N. Determination of N-acetylglucosaminyltransferases III, IV and V in normal and hepatoma tissues of rats. Biochim. Biophys. Acta 1990; 1035: 313-18.
10. Mori S, Aoyagi Y, Yanagi M, Suzuki Y, Asakura H. Serum N-acetylglucosaminyltransferase III activities in hepatocellular carcinoma. J. Gastroenterol. Hepatol. 1998; 13: 610-19.
11. Koenderman AHL, Koppen PL, Koeleman CAM, Van den Eijnden DH. N-acetylglucosaminyltransferase III, IV, V in Novikoff ascites tumor cells, mouse lymphoma cells and hen oviduct. Eur. J. Biochem. 1989; 181: 651-5.
12. Narasimhan S, Lee JWW, Cheung RK, Gelfand EW, Schachter H. β1,4-mannosyl-glycoprotein beta-1,4-N-acetylglucosaminyltransferase III activity in human B and T lymphocyte lines and in tonsillar B and T lymphocytes. Biochem. Cell Biol. 1988; 66: 889-900.
13. Brockhausen I, Romero PA, Herscovics A. Glycosyltransferase changes upon differentiation of CaCo-2 human colonic adenocarcinoma cells. Cancer Res. 1991; 51: 3136-42.
14. Ohno M, Nishikawa A, Koketsu M et al. Enzymatic basis of sugar structures of alpha-fetoprotein in hepatoma and hepatoblastoma cell lines: correlation with activities of α1-6 fucosyltransferase and N- acetylglucosaminyltransferases III and V. Int. J. Cancer 1992; 51: 315-17.
15. Koenderman AHL, Wijermans PW, Van den Eijnden DH. Changes in the expression of N-acetylglucosaminyltransferase III, IV, V associated with the differentiation of HL-60 cells. FEBS Lett. 1987; 222: 42-6.
16. Ihara Y, Nishikawa A, Tohma T, Nikawa N, Taniguchi N. cDNA cloning, expression and chromosomal localization of human N-acetylglucosaminyltransferase III (GnT-III). J. Biochem. 1993; 13: 692-8.
17. Kim YJ, Park JH, Kim KS et al. Sequence analysis of the 5′-flanking region of the gene encoding human N-acetylglucosaminyltransferase III. Gene 1996; 170: 281-3.
18. Nishikawa A, Ihara Y, Hatakeyama M, Kangawa M, Taniguchi N. Purification, cDNA cloning, and expression of UDP-N-acetylglucosamine β-D-mannoside β-1,4N-acetylglucosaminyltransferase III from rat kidney. J. Biol. Chem. 1992; 267: 18199-204.
19. Shim JK, Park C, Song EY, Lee YC, Chung TW, Kim CH. Differential expression of N-acetylglucosaminyltransferase-III and V activities in human hepatoma cells and colon cancer cells: implication of cancer specific-glycoantigen synthesis in malignamt transformation. Kor. J. Chitin & Chitosan 1997; 2: 27-39.
20. Park C, Jin UH, Lee YC, Kim CH. Characterization of UDP-N- acetylglucosamine: β-6-D-mannoside β-1,6-N- acetylglucosaminyltransferase V from a human hepatoma cell line Hep3B. Arch. Biochem. Biophys. 1999; 367: 281-8.
21. Song EY, Lee YC, Park YG et al. Expression of bisecting N-acetylglucosaminyltransferase-III in human hepatoma cell lines of Hep3B and HepG2. Cancer Invest. 2001; 19: 799-807.
22. Ganem D, Varmus HE. The molecular biology of the hepatitis B viruses. Annu. Rev. Biochem. 1987; 56: 651-93.
23. McDougal JS, Kennedy MS, Sligh JM, Cort SP, Mawle A, Nicholson JK. Binding of HTLV-III/LAV toT4+T cells by a complex of the 110K viral protein and the T4 molecule. Science 1986; 231: 382-5.
24. Mizuochi T, Matthews TJ, Kato M et al. Diversity of oligosaccharide structures on the envelope glycoprotein gp 120 of human immunodeficiency virus 1 from the lymphoblastoid cell line H9. Presence of complex-type oligosaccharides with bisecting N-acetylglucosamine residues. J. Biol. Chem. 1990; 265: 8519-24.
25. Felkner RH, Roth MJ. Mutational analysis of the N-linked glycosylation sites of the SU envelope protein of moloney murine leukemia virus. J. Virol. 1992; 66: 4258-64.
26. Block TM, Lu X, Platt FM et al. Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin. Proc. Natl Acad. Sci. USA 1994; 91: 2235-9.
27. Lu X, Mehta A, Dwek R, Butters T, Block T. Evidence that N-linked glycosylation is necessary for hepatitis B virus secretion. Virology 1995; 213: 660-5.
28. Miyoshi E, Nishikawa A, Ihara Y et al. Selective suppression of N-acetylglucosaminyltransferase III activity in a human hepatoblastoma cell line transfected with hepatitis B virus. Cancer Res. 1994; 54: 1854-8.
29. Tsurimoto T, Fujiyama A, Matsubara K. Stable expression and replication of hepatitis B virus genome in an integrated state in a human hepatoma cell line transfected with the cloned viral DNA. Proc. Natl Acad. Sci. USA 1987; 84: 444-8.
30. Miyoshi E, Ihara Y, Hayashi N, Fusamoto H, Kamada T, Taniguchi N. Transfection of N-acetylglucosaminyltransferase III gene suppresses expression of hepatitis B virus in a human hepatoma cell line, HB611. J. Biol. Chem. 1995; 270: 28311-15.
31. Shim JK, Kim DW, Chung TH et al. Characterization of a cell line HFH-T2, producing viral particles, from primary human fetal hepatocytes infected with hepatitis B virus. J. Microbiol. Biotechnol. 2001; 11: 186-92.
32. Chung, TW, Moon SK, Lee YC, Kim JG, Ko JH, Kim CH. Enhanced expression of matrix metalloproteinase-9 (MMP-9) by hepatitis B virus (HBV) infection into liver cells. Arch. Biocehm. Biophys. 2002; 408: 147-54.
33. Chung TW, Lee YC, Ko JH, Kim CH. Hepatitis B virus X protein modulates the expression of PTEN by inhibiting the function of p53, transcriptional activator in liver cells. Cancer Res. 2003; 63: 3453-8.
34. Hase S, Ibuki T, Ikenaka T. Reexamination of the pyridylamination used for fluorescence labeling of oligosaccharides and its application to glycoproteins. J. Biochem. 1984; 95: 197-203.
35. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid uanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987; 162: 156-9.
36. Schachter H. Biosynthetic controls that determine the branching and microheterogeneity of protein-bound oligosaccharides. Biochem. Cell Biol. 1990; 64: 163-81.
37. Song EY, Kim KS, Kim KA et al. Determination of UDP-N-acetylglucosamine: β-D-mannoside-1,4-N-acetylglucosaminyltransferase-III in patients sera with chronic hepatitis and liver cirrhosis using a monoclonal antibody. Glycoconj. J. 2002; 19: 415-21.
38. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
39. Lowry OH, Rosenbrough NH, Farr AL, Randall H. Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951; 193: 265-75.
40. Galle PR, Hagelstein J, Kommerell B, Volkmann M, Schranz P, Zentgraf H. In vitro experimental infection of primary human hepatocytes with hepatitis B virus. Gastroenterology 1994; 106: 664-73.
41. Gripon P, Diot C, Theze N et al. Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide. J. Virol. 1988; 62: 4136-43.
42. Ochiya T, Tsurimoto T, Ueda K, Okubo K, Shiozawa M, Matsubara K. An in vitro system for infection with hepatitis B virus that uses primary human fetal hepatocytes. Proc. Natl Acad. Sci. USA 1989; 86: 1875-9.
43. Rijntjes PJ, Moshage HJ, Yap SH. In vitro infection of primary cultures of cryopreserved adult human hepatocytes with hepatitis B virus. Virus Res. 1988; 10: 95-109.
44. Gripon P, Diot C, Guguen-Guillouzo C. Reproducible high level infection of cultured adult human hepatocytes by hepatitis B virus: effect of polyethylene glycol on adsorption and penetration. Virology 1993; 192: 534-40.
45. Isom HC, Georgoff I. Quantitative assay for albumin-producing liver cells after simian virus 40 transformation of rat hepatocytes maintained in chemically defined medium. Proc. Natl Acad. Sci. USA 1984; 81: 6378-82.
46. Park JW, Lee HS, Park JB, Kim CY. Establishment of continuous human fetal hepatocytes cell line by transfection of simian virus 40 T gene. Mol. Cells 1996; 6: 534-40.
47. Aden DP, Fogel A, Plotkin S, Damjanov I, Knowles BB. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature 1979; 282: 615-16.
48. Knowles BB, Howe CC, Aden DP. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 1980; 209: 497-9.
49. Miyoshi E, Ihara Y, Nishikawa A et al. Gene expression of N-acetylglucosaminyltransferases III and V: a possible implication for liver regeneration. Hepatology 1995; 22: 1847-55.
50. Dennis JW. Asn-linked oligosaccharide processing and malignant potential. Cancer Surv. 1988; 7: 573-795.
51. Nakao H, Nishikawa A, Karasuno T et al. Modulation of N-acetylglucosaminyltransferase III, IV and V activities and alteration of the surface oligosaccharide structure of a myeloma cell line by interleukin 6. Biochem. Biophys. Res. Commun. 1990; 172: 1260-6.
52. Gu TX, Meng XW, Tang H, Chen HL. High performance liquid chromatographic determination of N-acetylglucosaminyltransferase V during N-nitrosodiethylamine induced rat hepatocarcinoma. Chin. Biochem. J. 1993; 9: 653-8.
53. Gu TX, Meng XW, Tang H, Chen HL. High performance liquid chromatographic determination of N-acetylglucosaminyltransferase III during induced hepatocarcinoma in rat with N-nitrosodiethylamine. Acta Biochim. Biophys. Sinica. 1992; 24: 46-54.
54. Zhu TY, Chen HL, Gu JX, Zhang YF, Zhang YK, Zhang RA. Changes in N-acetylglucosaminyltransferase III, IV and V in renal cell carcinoma. J. Cancer Res. Clin. Oncol. 1997; 123: 296-9.